VRNA vs. IREN

Last updated Jun 13, 2026

VRNA (Verona Pharma plc) and IREN (IREN Limited) are both stocks. VRNA operates in Biotechnology (Healthcare), while IREN operates in Capital Markets (Financial Services). At a 0.18 correlation, their price movements are largely independent.

Performance

VRNA vs. IREN - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Verona Pharma plc (VRNA) and IREN Limited (IREN). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

VRNA

• 1D: —
• 1M: —
• YTD: —
• 6M: —
• 1Y: —
• 3Y*: —
• 5Y*: —
• 10Y*: —

IREN

• 1D: 5.40%
• 1M: 12.90%
• YTD: 58.25%
• 6M: 48.94%
• 1Y: 508.04%
• 3Y*: 155.58%
• 5Y*: —
• 10Y*: —

*Multi-year figures are annualized to reflect compound growth (CAGR)

VRNA vs. IREN - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021
VRNA Verona Pharma plc	0.00%	130.21%	133.60%	-23.92%	288.84%	26.08%
IREN IREN Limited	58.25%	284.62%	37.34%	472.00%	-92.27%	-42.25%

Correlation

The correlation between VRNA and IREN is 0.08, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.

	Correlation
Correlation (1Y) Calculated over the trailing 1-year period	0.08
Correlation (3Y) Calculated over the trailing 3-year period	0.17
Correlation (All Time) Calculated using the full available price history since Nov 17, 2021	0.18

The correlation between VRNA and IREN shifts across timeframes, from 0.08 (1 year) to 0.18 (all time), reflecting how their relationship changes across market environments.

Fundamentals

EPS VRNA : -$0.69 IREN : $0.45
PS Ratio VRNA : 57.97 IREN : 13.39
Total Revenue (TTM) VRNA : $167.65M IREN : $757.07M
Gross Profit (TTM) VRNA : $159.52M IREN : $433.88M
EBITDA (TTM) VRNA : -$40.86M IREN : -$173.05M

Return for Risk

VRNA vs. IREN — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

VRNA

Risk / return metrics aren't available yet — we need at least 12 months of trading data to calculate them.

IREN

IREN Risk / Return Rank: 95
IREN Sharpe Ratio Rank: 99
IREN Sortino Ratio Rank: 94
IREN Omega Ratio Rank: 91
IREN Calmar Ratio Rank: 97
IREN Martin Ratio Rank: 94

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

VRNA vs. IREN - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Verona Pharma plc (VRNA) and IREN Limited (IREN). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.

	VRNA	IREN	Difference
Sharpe ratio: Return per unit of total volatility	—	4.76	—
Sortino ratio: Return per unit of downside risk	—	3.66	—
Omega ratio: Gain probability vs. loss probability	—	1.42	—
Calmar ratio: Return relative to maximum drawdown	—	8.39	—
Martin ratio: Return relative to average drawdown	—	15.97	—

Drawdowns

Drawdown Indicators

	VRNA	IREN	Difference
Max Drawdown Largest peak-to-trough decline	—	-96.21%	—
Max Drawdown (1Y) Largest decline over 1 year	—	-58.62%	—
Max Drawdown (3Y) Largest decline over 3 years	—	-65.56%	—
Current Drawdown Current decline from peak	—	-21.78%	—
Average Drawdown Average peak-to-trough decline	—	-65.42%	—
Ulcer Index Depth and duration of drawdowns from previous peaks	—	30.74%	—

Volatility

Volatility by Period

	VRNA	IREN	Difference
Volatility (1M) Calculated over the trailing 1-month period	—	34.10%	—
Volatility (6M) Calculated over the trailing 6-month period	—	75.79%	—
Volatility (1Y) Calculated over the trailing 1-year period	—	103.25%	—
Volatility (5Y) Calculated over the trailing 5-year period, annualized	—	118.61%	—
Volatility (10Y) Calculated over the trailing 10-year period, annualized	—	118.61%	—

Dividends

VRNA vs. IREN - Dividend Comparison

Neither VRNA nor IREN has paid dividends to shareholders.

Tickers have no history of dividend payments

Financials

Frequently Asked Questions

Can I hold both VRNA and IREN in my portfolio?

VRNA and IREN have a correlation of 0.08, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.